• VOLOCIXIMAB chembl:CHEMBL2108061 Antineoplastic

    Alternate Names:

    M-200
    VOLOCIXIMAB
    M200

    Drug Info:

    Drug Class monoclonal antibody
    Drug Indications antineoplastic agent
    FDA Approval not approved
    (2 More Sources)

    Publications:

  • Interaction Types & Directionality:
    antagonist (inhibitory)
    antibody (inhibitory)

    Interaction Info:
    Mechanism of Interaction Integrin alpha-5/beta-1 antagonist
    Direct Interaction yes
    Details of the Assay for Interaction Binding affinity to human α5β1-Fc, determined using BIAcore SPR technology.

    Publications:

  • Interaction Types & Directionality:
    antagonist (inhibitory)
    antibody (inhibitory)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Integrin alpha-5/beta-1 antagonist
    Details of the Assay for Interaction Binding affinity to human α5β1-Fc, determined using BIAcore SPR technology.

    Publications:

  • Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Established target
    Trial Name volociximab, E10030, Eos200-4

    Publications: